Press Releases

Aug 01, 2022
BILLERICA, Mass. --(BUSINESS WIRE)--Aug. 1, 2022-- Quanterix Corporation (NASDAQ: QTRX), a company expanding the limits of exploration with ultrasensitive biomarker detection, today announced it will host a conference call on Monday, August 8, 2022 , to discuss its second quarter 2022 financial
Jun 06, 2022
BILLERICA, Mass. --(BUSINESS WIRE)--Jun. 6, 2022-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Karen A. Flynn , Senior Vice President and Chief Commercial Officer of Catalent Pharma
May 10, 2022
Quanterix reports continued revenue growth as it scales to support transformational advances in neurology research BILLERICA, Mass. --(BUSINESS WIRE)--May 10, 2022-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision
Displaying 1 - 10 of 24